AC Immune’s stock jumps after Parkinson’s therapy shows signs of benefit
AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...
GlobalData on MSN3d
DMTs are major clinical research focus for Parkinson’s disease, analysis shows
Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...
Lesser-known symptoms of diabetes, heart disease, dementia and Parkinson’s
Dementia is the umbrella term for all kinds of conditions associated with memory loss of which Alzheimer’s disease is the ...
Researchers identify a potential biomarker of Parkinson's disease progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...
Neuroscience News12d
RNA Structures Linked to Parkinson’s Protein Aggregates
Researchers have identified unique RNA structures called G-quadruplexes (G4s) that promote harmful α-synuclein protein ...
Benzinga.com1d
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
Patients from Part 2 will be evaluated for the progression of motor and non-motor symptoms and digital ... validated ...
biopharma-reporter1d
Promising early Parkinson’s immunotherapy results for AC Immune
The interim phase 2 trial results show a good immune response in participants and the therapy is well tolerated to date.
Medscape21h
Nonmotor Symptoms in Parkinson's Disease: The Dark Side of the Moon
This article describes these nonmotor symptoms and their management. Clinical diagnosis of Parkinson's disease (PD) could be performed in the presence of motor symptoms such as resting tremor ...
Live Science on MSN9d
E. coli in the gut may fuel a 'chain reaction' leading to Parkinson's, early study suggests
Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.
The Pharma Letter4d
Growing emphasis on disease-modifying therapies in Parkinson’s
The Parkinson’s disease (PD) therapeutic landscape is heavily genericized, leaving substantial unmet needs in neuroprotective ...
Armed robbery in Revesby3d
Biomarker Found for Parkinson's Disease Progression
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...